Aspiriant LLC
GSK icon

Aspiriant LLC’s GSK GSK Stock Holding History

Aspiriant LLC’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-10,267
Closed -$538K – 439
2026
Q2 		$538K Buy
10,267
+1,773
+21% +$93.8K 0.01% 233
2026
Q1 		$469K Buy
8,494
+309
+4% +$16.7K 0.01% 228
2025
Q4 		$401K Buy
8,185
+185
+2% +$8.63K 0.01% 240
2025
Q3 		$345K Sell
8,000
-119
-1% -$4.65K 0.01% 234
2025
Q2 		$312K Sell
8,119
-122
-1% -$4.66K 0.01% 246
2025
Q1 		$319K Buy
+8,241
New +$302K 0.01% 230
2020
Q4 		– Sell
-4,960
Closed -$233K – 213
2020
Q3 		$233K Buy
+4,960
New +$249K 0.02% 198
2018
Q2 		– Sell
-5,040
Closed -$246K – 253
2018
Q1 		$246K Buy
+5,040
New +$235K 0.02% 212

Other funds holding GSK

Mondrian Investment Partners
Mondrian Investment Partners London, United Kingdom $5.39B AUM 14.53% 1-Year Est. Return
BI Asset Management Fondsmaeglerselskab
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return
Douglas Lane & Associates
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
ABC Arbitrage
ABC Arbitrage Paris, France $1.02B AUM 30.46% 1-Year Est. Return
Foster Victor Wealth Advisors
Foster Victor Wealth Advisors Greenville, South Carolina $2.02B AUM 20.94% 1-Year Est. Return
Sound Income Strategies
Sound Income Strategies Ft Lauderdale, Florida $2.24B AUM 8.38% 1-Year Est. Return
Euro Pacific Asset Management
Euro Pacific Asset Management Dorado, Puerto Rico $1.22B AUM 22.48% 1-Year Est. Return
Keystone Financial Planning
Keystone Financial Planning Cleveland, Ohio $404M AUM 16.77% 1-Year Est. Return
Bell Bank
Bell Bank Fargo, North Dakota $2.66B AUM 18.07% 1-Year Est. Return

Aspiriant LLC's GSK Position: Q3 2026 in Review

Aspiriant LLC sold out of GSK (GSK) in Q3 2026, closing a stake of 10,267 shares — an estimated $538K sold.

Aspiriant LLC first reported a position in GSK in Q1 2018 and held it in 8 quarters. The position peaked at $538K in Q2 2026. 266 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • Aspiriant LLC reported no remaining GSK position as of Q3 2026 after selling out during the quarter.
  • Aspiriant LLC sold 10,267 GSK shares in Q3 2026, an estimated $538K.
  • Aspiriant LLC first reported a position in GSK in Q1 2018 and held it in 8 quarters.
  • Aspiriant LLC's GSK position peaked at $538K in Q2 2026.
  • 266 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Aspiriant LLC's 13F filing for Q3 2026, filed 16 Oct 2026.